We are grateful to CureSearch for Children's Cancer for the $40,000 grant to pursue our proposal, COG-STS Preclinical Targeted
Agent Trial Design Support. Through this project we will provide the Children's Oncology Group Soft Tissue Sarcoma committee with real-time testing of a targeted therapeutic for rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas. Unraveling rhabdomyosarcoma, osteosarcoma, dipg and medulloblastoma using engineering, biomedical, and translational research tools.
Wednesday, August 22, 2012
Our thanks to CureSearch!
We are grateful to CureSearch for Children's Cancer for the $40,000 grant to pursue our proposal, COG-STS Preclinical Targeted
Agent Trial Design Support. Through this project we will provide the Children's Oncology Group Soft Tissue Sarcoma committee with real-time testing of a targeted therapeutic for rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment